Skip to main content
. 2025 Sep 24;14(19):1497. doi: 10.3390/cells14191497
AD Alzheimer’s disease
AKT Protein kinase B
ALS Amyotrophic lateral sclerosis
ApoE Apolipoprotein E
APP amyloid precursor protein
ATP Adenosine triphosphate
Aβ amyloid-beta plaques
BBB Blood–brain barrier
BDNF Brain-derived neurotrophic factor
C9ORF72 Chromosome 9 open reading frame 72
AA Cerebral amyloid angiopathy
CAG Cytosine, Adenine, Guanine trinucleotide
CBP CREB-binding protein
CCL2 Chemokine (C-C motif) ligand 2
CD4 cells Clusters of differentiation 4
CD8 Clusters of differentiation 8
CNS Central nervous system
CREB cAMP-response element binding protein
DMTs Disease-modifying therapies
DP1 D-type prostanoid receptor 1
EAATs Excitatory amino acid transporters
EBV Epstein–Barr virus
FALS Familial Amyotrophic Lateral Sclerosis
FUS Fused in sarcoma genes
GDNF Glial cell line-derived neurotrophic factor
GFAP Glial fibrillary acidic protein
HLA-DRB1 Human Leucocyte Antigen DR Beta 1
HTT Huntingtin gene
iPSCs Induced pluripotent stem cells
IR4.1 Inwardly rectifying potassium channel 4.1
LMNs Lower motor neurons
LRRK2 Leucine-rich repeat kinase 2
LTD long-term depression
LTP long-term potentiation
mHTT Mutant huntingtin protein
MS Multiple sclerosis
MSNs Medium spiny neurons
NF-κB Nuclear factor kappa B
NFTs neurofibrillary tangles
NMDA N-methyl-D-aspartate
OPCs Oligodendrocyte precursor cells
PARK7 Parkinsonism Associated Deglycase
PD Parkinsons disease
PI3K Phosphatidylinositol 3-kinase
PolyQ Polyglutamine
PSEN1 Presenilin-1
PSEN2 Presenilin-2
RNA Ribonucleic acid
ROS Reactive oxygen species
sALS Sporadic ALS
SNCA Synuclein alpha
sNpc Substantia nigra pars compacta
SOD1 Superoxide dismutase type 1
TARDBP Transactive response DNA-binding protein
TDP-43 Transactive response DNA-binding protein of 43 kDa
TNF-α Tumor necrosis factor alpha
UMNs Upper motor neurons
PS Ubiquitin-proteasome system
UV Ultraviolet r